Tamarack Advisers’s Sanofi SNY Stock Holding History

Tamarack Advisers’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,000	Closed	-$1.61M	–	13
2023 Q3	$1.61M	Sell	30,000 -65,000	-68%	-$3.47M	1.04%	17
2023 Q2	$5.12M	Hold	95,000	–	–	1.58%	13
2023 Q1	$5.17M	Buy	95,000 +45,000	+90%	+$2.19M	1.89%	16
2022 Q4	$2.42M	Sell	50,000 -105,000	-68%	-$4.61M	1.25%	25
2022 Q3	$5.89M	Buy	155,000 +60,000	+63%	+$2.67M	3.46%	11
2022 Q2	$4.75M	Buy	+95,000	New	+$5.04M	2.75%	17

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Tamarack Advisers's SNY Position: Q4 2023 in Review

Tamarack Advisers sold out of Sanofi (SNY) in Q4 2023, closing a stake of 30,000 shares — an estimated $1.61M sold.

Tamarack Advisers first reported a position in SNY in Q2 2022 and held it in 6 quarters. The position peaked at $5.89M in Q3 2022. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

Tamarack Advisers reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
Tamarack Advisers sold 30,000 Sanofi shares in Q4 2023, an estimated $1.61M.
Tamarack Advisers first reported a position in Sanofi in Q2 2022 and held it in 6 quarters.
Tamarack Advisers's Sanofi position peaked at $5.89M in Q3 2022.
709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Tamarack Advisers's 13F filing for Q4 2023, filed 9 Feb 2024.